Axial Therapeutics Inc.

As the scientific leader in the biological role of the microbiome gut-brain axis and its impact on neurological conditions, Axial Therapeutics is uniquely positioned to advance a fundamentally different therapeutic approach for the treatment of neurological diseases and disorders. We stand apart through our focus on the microbiome, harnessing our expertise to identify new drug targets in the gut and develop novel medical interventions that have significant potential for improving symptoms and treating underlying disease.